Multiple Myeloma
EU Focus Meeting 2026
📍 Courtyard by Marriott Vienna Prater/Messe, Trabrennstraße 4, 1020 Wien, Austria
🗓️ October 30 - 31, 2026
Last Year's Highlights
CME Accreditation
MD Education will seek accreditation from the European Accreditation Council for Continuing Medical Education (EACCME). This will allow participants of the academy to earn CME credits, enhancing the educational value of their experience.
Dear Colleagues and Friends,
We are delighted to extend our warmest invitation to the Multiple Myeloma Focus Meeting 2026, to be held on October 30 - 31, 2026.
Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing Multiple Myeloma research and patient treatment.
This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.
Chairs of Multiple Myeloma EU Focus Meeting 2026:
Maria-Victoria Mateos
University Hospital of Salamanca, Spain
Philippe Moreau
The University Hospital of Nantes, France
Supporters to be announced...
Interested in supporting this meeting? Get in contact:
freya.symons@md-education.com
Agenda & Faculty
October 30, 2026 | Day 1
Session I: Novel Diagnostic Platforms and Precursor Disease States
Moderated by:
Maria-Victoria Mateos
University Hospital of Salamanca, Spain
09:00 AM
Replacing FISH with Sequencing Platforms
TBD
TBD
TBD
09:20 AM
Role of Mass Spectrometry in Diagnosis and Monitoring
Noemí Puig
University Hospital of Salamanca, Spain
09:40 AM
The Immune Landscape in Precursor Disease and Multiple Myeloma
Bruno Paiva
Universidad de Navarra, Pamplona, Spain
10:30 AM
Fellow/Junior Faculty CASE and Q&A
Alexis Talbot
Greater Paris University Hospitals, Paris, France
Session II: Newly Diagnosed Multiple Myeloma
Moderated by:
Philippe Moreau
The University Hospital of Nantes, France
11:05 PM
Quadruplets for ALL?
Xavier Leleu
Poitiers University Hospital, Poitiers, France
11:25 PM
Defining Frailty and Treatment of Frail Patients
Salomon Manier
Centre Hospitalier Universitaire de Lille, France
11:45 PM
Tailoring the Maintenance Regimen and Duration
Elena Zamagni
University of Bologna, Italy
12:35 PM
Fellow/Junior Faculty CASE and Q&A
BP
Benedicte Piron
The University Hospital of Nantes, France
Session III: High Risk Disease
Moderated by:
Katja Weisel
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
02:25 PM
Defining High Risk Disease
LL
Lisa Leypoldt
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
02:45 PM
Should High Risk Disease be Treated Differently?
Maria Theresa Krauth
Medical University of Vienna, Austria
03:05 PM
Clinical Trials Targeting High Risk Disease
Katja Weisel
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
03:55 PM
Case Discussion and Q&A
Leon Cords
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Session IV: Relapse MM
Moderated by:
Maria-Victoria Mateos
University Hospital of Salamanca, Spain
04:30 PM
Approaching Disease Relapse - Treatment Approaches Excluding Immunotherapies
Paula Rodríguez Otero
Clínica Universidad de Navarra, Spain
04:50 PM
Belamaf: The Comeback Kid?
Evangelos Terpos
University of Athens, Greece
05:10 PM
Targeted therapy in RR MM: BCL2i, MMSET, BRAF
Marc Raab
Heidelberg Myeloma Center, Germany
06:00 PM
Fellow/Junior Faculty CASE and Q&A
Borja Puertas
University Hospital of Salamanca, Spain
October 31, 2026 | Day 2
Session V: Immunotherapies in MM
Moderated by:
Philippe Moreau
The University Hospital of Nantes, France
09:00 AM
Use of Bispecifics in MM
Niels van de Donk
Amsterdam UMC, Netherlands
09:20 AM
CAR-T Cells in MM
Hermann Einsele
Würzburg University Hospital, Germany
09:40 AM
Novel Targets and Newer Approaches
AL
Alessandra Larocca
University Hospital Città della Salute e della Scienza, Torino, Italy
10:30 AM
Fellow/Junior Faculty CASE and Q&A
Michele Puppi
University of Bologna, Italy
Session VI: Other Plasma Cell Disorders
Moderated by:
Maria-Victoria Mateos
University Hospital of Salamanca, Spain
11:05 AM
CAR-T Cells in MMAL Amyloidosis
Paolo Milani
IRCCS Policlinico San Matteo, Pavia, Italy
11:25 AM
Waldenstroms
Ramón García Sanz
University Hospital of Salamanca, Spain
12:15 PM
Fellow/Junior Faculty CASE and Q&A
EA
Elham Askari
Fundacion Jimenez Diaz University Hospital, Madrid, Spain
Freya Symons
Associate Project Manager
How long has Freya Symons been in the business?
Freya Symons has been with MD Education since 2025.
About Freya Symons
As an Associate Project Manager at MD Education’s Wigan office, I support the smooth delivery of educational events through effective coordination, organisation, and communication. With a strong background in project-based work and a degree in Business Management and Marketing, I take pride in my attention to detail and ability to build positive working relationships. I am committed to supporting project teams and contributing to the delivery of high-quality projects. For me, seeing projects develop from initial ideas to successful delivery is what makes the role so rewarding.
